Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Bicycle Therapeutics plc American Depositary Shares (BCYC)

Pharmaceutical Preparations

https://www.bicycletherapeutics.com

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON
CAMBRIDGE, X0

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/23/2019

Market Cap

1,554,969,713

Shares Outstanding

37,720,000

Weighted SO

37,715,666

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

IDYA --.--%

ANAB --.--%

MGTX --.--%

KROS --.--%

FIXX --.--%

TNYA --.--%

IGMS --.--%

GLUE --.--%

STOK --.--%

Beta

0.9340

Last Div

0.0000

Range

12.54-27.24

Chg

-0.1650

Avg Vol

282616

Mkt Cap

1554969713

Exch

NASDAQ

Country

GB

Phone

44 1223 261 503

DCF Diff

49.3516

DCF

-23.9816

Div Yield

0.0000

P/S

39.2934

EV Multiple

-3.3640

P/FV

1.3420

Div Yield %

0.0000

P/E

-7.0899

PEG

-0.2893

Payout

0.0000

Current Ratio

14.7715

Quick Ratio

14.7715

Cash Ratio

13.8105

DSO

430.5105

DIO

0.0001

Op Cycle

430.5106

DPO

409.2301

CCC

21.2805

Gross Margin

0.8320

Op Margin

-5.2207

Pretax Margin

-4.6925

Net Margin

-4.1796

Eff Tax Rate

0.1093

ROA

-0.1564

ROE

-0.3280

ROCE

-0.2092

NI/EBT

0.8907

EBT/EBIT

0.8988

EBIT/Rev

-5.2207

Debt Ratio

0.0341

D/E

0.0412

LT Debt/Cap

0.0096

Total Debt/Cap

0.0396

Int Coverage

-126.6704

CF/Debt

-4.5504

Equity Multi

1.2100

Rec Turnover

0.8478

Pay Turnover

0.8919

Inv Turnover

999999.9999

FA Turnover

1.7573

Asset Turnover

0.0374

OCF/Share

-3.1514

FCF/Share

-3.1703

Cash/Share

18.4906

OCF/Sales

-4.1403

FCF/OCF

1.0060

CF Coverage

-4.5504

ST Coverage

-5.9576

CapEx Coverage

-166.3175

Div&CapEx Cov

-166.3175

P/BV

1.3420

P/B

1.3420

P/S

39.2934

P/E

-7.0899

P/FCF

-9.4338

P/OCF

-7.1572

P/CF

-7.1572

PEG

-0.2893

P/S

39.2934

EV Multiple

-3.3640

P/FV

1.3420

DPS

0.0000

Latest Headlines (EST)

Benzinga Nov 03, 17:00 Expert Ratings for Bicycle Therapeutics Benzinga Nov 03, 17:00 Expert Ratings for Bicycle Therapeutics

Revenue Product Segmentation